Literature DB >> 4202672

Antibiotic levels in pericardial fluid.

J S Tan, J C Holmes, N O Fowler, G T Manitsas, J P Phair.   

Abstract

An experimental model was designed to study the ability of antibiotics to enter the pericardial compartment. Noninfected and infected pericardial fluid and serum antibiotic activities were determined in adult mongrel dogs before and at intervals after antibiotic administration. After the administration of penicillin G, methicillin, cephaloridine, streptomycin, or gentamicin, clinically adequate antibiotic levels in the noninfected pericardial fluid were obtained within 1 h, and these levels approached or exceeded the serum levels within 2-4 h. Antibiotic levels obtained from infected dog pericardial fluids were higher than those from noninfected animals. Patients' serum and pericardial fluid antibiotic levels were measured after penicillin G, penicillin V, cephalothin, and gentamicin administration. We have found, both in the canine and human studies, that pericardial antibiotic levels taken at least 2 h after antibiotic administration are almost identical to those in the blood.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4202672      PMCID: PMC301432          DOI: 10.1172/JCI107561

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  8 in total

1.  The effect of probenecid upon serum levels of methicillin.

Authors:  W R HENDERSON; J CARLETON; M HAMBURGER
Journal:  Am J Med Sci       Date:  1962-04       Impact factor: 2.378

2.  Treatment of nontuberculous bacterial pleural space infections with aureomycin: results of treatment in nine patients; concentration of aureomycin in pleural and pericardial fluid in seven patients.

Authors:  C K WOLFE; M H LEPPER; E R CALDWELL; H W SPIES; H F DOWLING
Journal:  Ann Intern Med       Date:  1952-07       Impact factor: 25.391

3.  A method for measurement of antibiotics in human interstitial fluid.

Authors:  J S Tan; A Trott; J P Phair; C Watanakunakorn
Journal:  J Infect Dis       Date:  1972-11       Impact factor: 5.226

4.  Serum protein binding of the aminoglycoside antibiotics.

Authors:  R C Gordon; C Regamey; W M Kirby
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191

5.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

6.  The binding of antibiotics to serum proteins.

Authors:  G N Rolinson; R Sutherland
Journal:  Br J Pharmacol Chemother       Date:  1965-12

7.  Gentamicin: in vitro studies.

Authors:  W M Kirby; H C Standiford
Journal:  J Infect Dis       Date:  1969 Apr-May       Impact factor: 5.226

8.  Pharmacology of gentamicin in man.

Authors:  L J Riff; G G Jackson
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

  8 in total
  5 in total

1.  A pneumococcal purulent pericarditis revealing a pneumonia and complicated by an acute cardiac tamponade.

Authors:  Pierrick Cronier; Baptiste Eugène; Stéphanie Passefort; Raymond Gryman
Journal:  J Cardiol Cases       Date:  2011-11-04

2.  Effect of protein concentration and binding on antibiotic assays.

Authors:  L R Peterson; E A Schierl; W H Hall
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

3.  Levels of carbenicillin, ticarcillin, cephalothin, cefazolin, cefamandole, gentamicin, tobramycin, and amikacin in human serum and interstitial fluid.

Authors:  J S Tan; S J Salstrom
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

4.  Choice of antibiotics for serious infections in children.

Authors:  A N Prasad; R K Marwaha
Journal:  Indian J Pediatr       Date:  1984 May-Jun       Impact factor: 1.967

5.  Comparative penetration of cefonicid and cefazolin into the atrial appendage and pericardial fluid of patients undergoing open-heart surgery.

Authors:  M N Dudley; C H Nightingale; A D Drezner; H B Low; R Quintiliani
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.